Submit Buy Request
View Synopsis & Table of contentDiscover the latest market analysis on Guillain-Barré Syndrome treatments, revealing a $539.5M market in 2025 projected for significant growth driven by IVIG, plasma exchange, and rising prevalence. Explore regional insights, key players (Grifols, CSL Behring, Octapharma), and future market trends.
Total Amount: $0
$8960.00
$6720.00
$4480.00
Our Clients
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.
Key Highlights of Report
Apr, 2025
100
Tables
Base Year: 2025.
Coverage: 18 Countries
Companies: 15+
Connect With us
